Showing results (1-10 of 512) with videos related to
Sort By:
Pageof 52
Nature Reviews. Neurology|April 3, 2019
Author Correction: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia AmatoJournal of the Neurological Sciences|April 10, 2014
Emotional and neutral verbal memory impairment in Multiple SclerosisPietro Iaffaldano, Rosa Gemma Viterbo, Benedetta Goretti, et al.European Journal of Neurology|July 3, 2021
First-line therapies in late-onset multiple sclerosis: An Italian registry studyAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.Frontiers in Neurology|April 1, 2022
Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple SclerosisMaria Pia Amato, Nicola De Stefano, Matilde Inglese, et al.Multiple Sclerosis and Related Disorders|January 15, 2022
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS registerAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.Expert Opinion on Pharmacotherapy|October 6, 2004
Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agentsMaria Pia AmatoMultiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2017
The diagnostic dilemma of multiple sclerosis presenting with isolated cognitive and behavioral disordersMaria Pia AmatoJournal of Neurology|May 3, 2002
The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in ItalyMaria Pia Amato, Mario A Battaglia, Domenico Caputo, et al.Journal of Neurology|May 27, 2025
Personalized therapy in multiple sclerosis: an Italian Delphi consensusClaudio Gasperini, Diego Centonze, Antonella Conte, et al.Journal of Neurology|August 10, 2025
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensusMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.Pageof 52